Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
Journal of Hepatology
|
July 25, 2000
Downregulation of ileal bile acid absorption in bile-duct-ligated rats
P Sauer, A Stiehl, B A Fitscher, et al.
Journal of Orthopaedic Trauma
|
October 16, 2020
Measuring Lateral Screw Protuberance Is a Clinically Accurate Method for Quantifying Femoral Neck Shortening
Aresh Sepehri, James Martinson, Lucas S Marchand, et al.
The Pharmacogenomics Journal
|
October 24, 2012
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients
A Habtewold, W Amogne, E Makonnen, et al.
Blood
|
November 26, 1999
HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells
H D Riedel, M U Muckenthaler, S G Gehrke, et al.
Physical Review Letters
|
February 2, 2013
Resonant addressing and manipulation of silicon vacancy qubits in silicon carbide
D Riedel, F Fuchs, H Kraus, et al.
Foot & Ankle International
|
January 29, 2019
Correlation of Soft Tissue Swelling and Timing to Surgery With Acute Wound Complications for Operatively Treated Ankle and Other Lower Extremity Fractures
Matthew D Riedel, Amber Parker, Mingxin Zheng, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 2010
Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients
E Ngaimisi, S Mugusi, O M Minzi, et al.
Clinical Pharmacology and Therapeutics
|
August 5, 2011
Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis
E Ngaimisi, S Mugusi, O Minzi, et al.
The Journal of Antimicrobial Chemotherapy
|
August 7, 2014
Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment
E Ngaimisi, O Minzi, S Mugusi, et al.
Cureus
|
April 1, 2024
Outcomes of Distal Third Femur Fractures in Patients 18 Years and Older: A Pilot Study
Gregory R Roytman, Sahir S Jabbouri, Jamieson O'Marr, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
Journal of Hepatology
|
July 25, 2000
Downregulation of ileal bile acid absorption in bile-duct-ligated rats
P Sauer, A Stiehl, B A Fitscher, et al.
Journal of Orthopaedic Trauma
|
October 16, 2020
Measuring Lateral Screw Protuberance Is a Clinically Accurate Method for Quantifying Femoral Neck Shortening
Aresh Sepehri, James Martinson, Lucas S Marchand, et al.
The Pharmacogenomics Journal
|
October 24, 2012
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients
A Habtewold, W Amogne, E Makonnen, et al.
Blood
|
November 26, 1999
HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells
H D Riedel, M U Muckenthaler, S G Gehrke, et al.
Physical Review Letters
|
February 2, 2013
Resonant addressing and manipulation of silicon vacancy qubits in silicon carbide
D Riedel, F Fuchs, H Kraus, et al.
Foot & Ankle International
|
January 29, 2019
Correlation of Soft Tissue Swelling and Timing to Surgery With Acute Wound Complications for Operatively Treated Ankle and Other Lower Extremity Fractures
Matthew D Riedel, Amber Parker, Mingxin Zheng, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 2010
Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients
E Ngaimisi, S Mugusi, O M Minzi, et al.
Clinical Pharmacology and Therapeutics
|
August 5, 2011
Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis
E Ngaimisi, S Mugusi, O Minzi, et al.
The Journal of Antimicrobial Chemotherapy
|
August 7, 2014
Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4β-hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment
E Ngaimisi, O Minzi, S Mugusi, et al.
Cureus
|
April 1, 2024
Outcomes of Distal Third Femur Fractures in Patients 18 Years and Older: A Pilot Study
Gregory R Roytman, Sahir S Jabbouri, Jamieson O'Marr, et al.
Page
of 16